Recall: Torrent Pharmaceuticals Limited Losartan Potassium Tablets, USP; Losartan Potassium And Hydrochlorothiazide Tablets, USP
On 2019-04-18, the FDA announced that Torrent Pharmaceuticals Limited is conducting a recall on Losartan Potassium Tablets, USP; Losartan Potassium And Hydrochlorothiazide Tablets, USP due to possible contamination with . The recalled products were sold under the brand name(s) Torrent Pharmaceuticals Limited during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 3 drugs recalls due to potential contamination, including baby cough syrup + mucus, white vein kratom and maeng da kratom and more. Additionally, there have been 24 drug and medical device recalls due to other health hazards as well as 80 food recalls.
Company Contact Information:
Name: Torrent Pharmaceuticals Limited
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Nationwide
Product Description: Losartan potassium tablets, USP; Losartan potassium and Hydrochlorothiazide tablets, USP
Brand Name(s): Torrent Pharmaceuticals Limited
Reason for Recall: Foreign Material Contamination
Official Recall Date: 2019-04-18
Additional information provided by the FDA.gov:
Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.